Protease Inhibitors (pis) - Infectious Diseases

Relevant Publications

HIV and adipose tissue: A long history linked to therapeutic classes of antiretrovirals.

Issue Release: 2024

Choice of antiretroviral therapy has low impact on weight gain.

Issue Release: 2024

Characteristics of drug resistance mutations in ART-experienced HIV-1 patients with low-level viremia in Zhengzhou City, China.

Issue Release: 2024

Antiretroviral Drug Repositioning for Glioblastoma.

Issue Release: 2024

Design of Novel Imidazole Derivatives as Potential Non-nucleoside Reverse Transcriptase Inhibitors Using Molecular Docking and Dynamics Strategies.

Issue Release: 2024

Comprehensive Database of HIV Mutations Selected During Antiretroviral In Vitro Passage Experiments.

Issue Release: 2024

Identification of novel genetic variations in ABCB6 and GRN genes associated with HIV-associated lipodystrophy.

Issue Release: 2024

Predictors of antiretroviral treatment failure to the first line therapy: a cross-sectional study among Iranian HIV-positive adults.

Issue Release: 2024

Incidence of low-level viremia and its impact on virologic failure among people living with HIV who started an integrase strand transfer inhibitors: a longitudinal cohort study.

Issue Release: 2024

Prevalence of acquired and transmitted HIV drug resistance in Iran: a systematic review and meta-analysis.

Issue Release: 2024

Full-Spectrum Surveillance of Pre-Treatment HIV Drug Resistance in Southeastern China.

Issue Release: 2024

Proteomic Analysis of HepG2 Cells Reveals FAT10 and BAG2 Signaling Pathways Affected by a Protease Inhibitor from (Willd.) Hook. f. and Thoms Stem. Extract Among the Different Plant and Microbial Samples Analyzed.

Issue Release: 2024

HIV-1 diversity and pre-treatment drug resistance in the era of integrase inhibitor among newly diagnosed ART-naïve adult patients in Luanda, Angola.

Issue Release: 2024

HIV-1 pretreatment and acquired antiretroviral drug resistance before tenofovir/ /lamivudine /dolutegravir (TLD) roll-out in Mozambique.

Issue Release: 2024

Improving Predictive Efficacy for Drug Resistance in Novel HIV-1 Protease Inhibitors through Transfer Learning Mechanisms.

Issue Release: 2024

Preclinical characterization of a non-peptidomimetic HIV protease inhibitor with improved metabolic stability.

Issue Release: 2024

Lipoxygenases regulate digestive enzyme inhibitor activities in developing seeds of field-grown soybean against the southern green stink bug (Nezara viridula).

Issue Release: 2024

Molecular network characteristics and drug resistance analysis of 392 newly reported MSM HIV/AIDS cases in Chongqing, China.

Issue Release: 2024

Applying Next-Generation Sequencing to Track HIV-1 Drug Resistance Mutations Circulating in Portugal.

Issue Release: 2024

Comprehensive characterization of protease inhibiting gene family, cis-regulatory elements, and protein interaction network in linseed and their expression upon bud fly infestation.

Issue Release: 2024

Are There Any Risks Associated with Stool Sample Collection?

What Types of Surveillance Systems Exist?

What are the future directions in HIV research?

What Role Do Governments and Organizations Play?

What is Clostridium Botulinum?

Are Asymptomatic Infections Less Severe?

What is the Treatment for Rabies?

What is the public health impact of Neisseria gonorrhoeae?

What are the Future Directions in Parasite DNA Research?

How is Schistosomiasis Diagnosed?

Protease Inhibitors (pis) - Infectious Diseases

Relevant Publications

Partnered Content Networks

Relevant Topics